New Product for High Resolution microCT

MediLumine’s NEW Mvivo gold nanoparticles enable long lasting vascular contrast for high resolution microCT.

• Low-dose
• Long lasting high resolution vascular contrast
• Ideal for tumor imaging studies

Mvivo Au
Image courtesy of Dr. Timothy Doyle, Stanford University

microCT of three mice 26 hours post-injection with Mvivo Au at doses of 100 uL (middle), 150 uL (bottom) and 200uL (top). The 150 uL and 200 uL doses are still clearly visible at this time point.

Share This Post

More To Explore

Come Visit Us at WMIC 2022 in Miami

We are looking forward to this year’s WMIC conference in Miami! Come meet Stephen Marchant (CEO MediLumine Inc.) and Felix Gremse (CEO Gremse-IT) at Booth

New Fenestra HDVC Publication

Fenestra HDVC is a non-toxic contrast agent for small animal in vivo microCT imaging.  Micro-computed tomography (micro-CT) imaging has been used to analyze organs in

Managed by Carbon Digital